Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577YAN SHI; CHI LI; KLEI, Herbert E et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 24, pp 6882-6889, issn 0960-894X, 8 p.Article

Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitorsYAN SHI; O'CONNOR, Stephen P; KLEI, Herbert E et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 24, pp 7516-7521, issn 0960-894X, 6 p.Article

Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYAN SHI; JING ZHANG; KISH, Kevin et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4034-4041, issn 0960-894X, 8 p.Article

Image Annotation and Database Mining to Create a Novel Screen for the Chemotype-Dependent Crystallization of HCV NS3 Protease: Published as part of the Crystal Growth & Design virtual special issue on the 13th International Conference on the Crystallization of Biological Macromolecules (ICCBM13)KLEI, Herbert E; KISH, Kevin; RUSSO, Mark F et al.Crystal growth & design. 2011, Vol 11, Num 4, pp 1143-1151, issn 1528-7483, 9 p.Article

Design, Structure-Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa InhibitorsYAN SHI; SITKOFF, Doree; YOUSSEF, Sonia et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 23, pp 7541-7551, issn 0022-2623, 11 p.Article

X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirKLEI, Herbert E; KISH, Kevin; SHERIFF, Steven et al.Journal of virology. 2007, Vol 81, Num 17, pp 9525-9535, issn 0022-538X, 11 p.Article

The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutantsTOKARSKI, John S; NEWITT, John A; DIANLIN XIE et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5790-5797, issn 0008-5472, 8 p.Article